Raymond James Trust N.A. purchased a new stake in shares of Tekla Healthcare Investors (NYSE:HQH) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 11,755 shares of the financial services provider’s stock, valued at approximately $272,000.
Other institutional investors have also recently made changes to their positions in the company. Stephens Inc. AR purchased a new position in shares of Tekla Healthcare Investors during the second quarter valued at $236,000. Coastline Trust Co purchased a new position in shares of Tekla Healthcare Investors during the third quarter valued at $239,000. PNC Financial Services Group Inc. increased its stake in shares of Tekla Healthcare Investors by 112.4% during the third quarter. PNC Financial Services Group Inc. now owns 11,646 shares of the financial services provider’s stock valued at $270,000 after buying an additional 6,164 shares during the period. IFP Advisors Inc increased its stake in shares of Tekla Healthcare Investors by 307.2% during the third quarter. IFP Advisors Inc now owns 14,994 shares of the financial services provider’s stock valued at $347,000 after buying an additional 11,312 shares during the period. Finally, National Asset Management Inc. purchased a new position in shares of Tekla Healthcare Investors during the third quarter valued at $415,000. Hedge funds and other institutional investors own 20.54% of the company’s stock.
In other news, President Daniel R. Omstead purchased 3,882 shares of the business’s stock in a transaction dated Wednesday, October 17th. The shares were purchased at an average price of $21.78 per share, for a total transaction of $84,549.96. Following the completion of the purchase, the president now owns 73,606 shares in the company, valued at approximately $1,603,138.68. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, President Daniel R. Omstead purchased 5,500 shares of the business’s stock in a transaction dated Thursday, October 25th. The shares were purchased at an average price of $20.43 per share, for a total transaction of $112,365.00. Following the purchase, the president now owns 79,106 shares of the company’s stock, valued at approximately $1,616,135.58. The disclosure for this purchase can be found here. Company insiders own 1.00% of the company’s stock.
The company also recently declared a quarterly dividend, which will be paid on Monday, December 31st. Stockholders of record on Wednesday, November 28th will be paid a dividend of $0.51 per share. The ex-dividend date is Tuesday, November 27th. This represents a $2.04 annualized dividend and a dividend yield of 9.65%. This is a positive change from Tekla Healthcare Investors’s previous quarterly dividend of $0.47.
COPYRIGHT VIOLATION NOTICE: This report was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.com-unik.info/2018/12/04/raymond-james-trust-n-a-invests-272000-in-tekla-healthcare-investors-hqh.html.
Tekla Healthcare Investors Profile
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More: Moving Average (MA)
Receive News & Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.